Acute coronary syndrome (ACS) — an umbrella term for situations where blood flow to the heart is suddenly obstructed — can lead to a heart attack if left untreated, and that’s obviously bad news. According to the Center for Disease Control and Prevention, over 610,000 people die of heart disease every year, which is the leading cause of death for both men and women in the U.S.

Fortunately, scientists at IBM and pharmaceutical giant AstraZeneca are investigating a framework that can suss out early ASC warning signs. It’s described in a newly published paper (““) on the preprint server Arxiv.org.

Read More At Article Source | Article Attribution